fashion -WSS

fashion

author：leisure time 2025-09-27 10:00:09 - browse：43

Stock illustration of computer and medication — Adobe

Digital therapeutics company Click Therapeutics announced Wednesday it will acquire the assets of Better Therapeutics, developer of a software-based treatment for diabetes. Click, which did not disclose how much it is paying for the assets, hopes to adapt Better’s tech for use alongside GLP-1 medications.

Better Therapeutics announced in March that it was delisting from the Nasdaq stock exchange and shutting down operations as it sought strategic alternatives. The company had been, since last year, searching for ways to stay afloat as its cash reserves dwindled.

Last, year, Better received Food and Drug Administration clearance for AspyreRx, a prescription app that delivers cognitive behavioral therapy and had been shown to reduce A1c levels in people with type 2 diabetes. Still, the company has been unable to ramp up significant commercial traction. Better also had a pipeline of other products targeting cardiometabolic conditions, and had made early claims about the benefits of AspyreRx in people taking GLP-1s for diabetes management.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The cancer drug shortage isn’t new — and neither are the solutions
Next article： Startling documents reveal new facets of Sacklers' opioid empire

WSS

UCSF medical school apologizes for unethical prisoner experiments

The new shift in health care is toward less care

UCSF medical school apologizes for unethical prisoner experiments

Diversify hospital leadership teams to protect BIPOC patient health

Readout Newsletter: Moderna bird flu vaccine, Biohaven, ASCO

HPV cancer vaccine study demonstrates efficacy

Wikipedia

fashion

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

focus

Hollywood unions extend contract negotiations for actors

Childbirth

Medicare proposal to cover medical devices draws a mixed reaction

UCSF medical school apologizes for unethical prisoner experiments

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

HPV cancer vaccine study demonstrates efficacy

Psychedelics group wrestles with new pharma identity

Addiction doctors spar with methadone clinics over legislation

The cancer drug shortage isn’t new — and neither are the solutions

Biotech incubator Curie.Bio graduates its first startup

entertainment

Abortion clinic in Cancun will cater to Americans

White House calls on federal agencies to crack down on AI abuses

AI used to predict Covid

Merck to buy EyeBio, maker of eye drug, as it grows pipeline

Study: New antibiotic targets gonorrhea as well as last existing drug

MoonLake credibility takes another hit with mid

focus

hotspot

hotspot

leisure time